Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Losartan	29
Overall Study	STARTED	Allopurinol	30
Overall Study	STARTED	Placebo	28
Overall Study	Received Intervention	Losartan	28
Overall Study	Received Intervention	Allopurinol	30
Overall Study	Received Intervention	Placebo	27
Overall Study	Did Not Receive Intervention	Losartan	1
Overall Study	Did Not Receive Intervention	Allopurinol	0
Overall Study	Did Not Receive Intervention	Placebo	1
Overall Study	Analyzed	Losartan	28
Overall Study	Analyzed	Allopurinol	30
Overall Study	Analyzed	Placebo	28
Overall Study	COMPLETED	Losartan	28
Overall Study	COMPLETED	Allopurinol	30
Overall Study	COMPLETED	Placebo	25
Overall Study	NOT COMPLETED	Losartan	1
Overall Study	NOT COMPLETED	Allopurinol	0
Overall Study	NOT COMPLETED	Placebo	3

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01637623/flow